Celldex CDX527-01 (Solid tumors)
What is the Purpose of this Study?
- Get the study drug (CDX-527) by IV
- Give tumor tissue
- Have physical exams, blood and urine tests
- Have heart scans (ECG)
- Have radiographs (X-rays)
- Have imaging scans (MRI and or CT)
Who Can Participate in this Study?
Adults who are diagnosed with ovarian cancer.
For more information about who can join this study, please contact the study team at CCI-TrialReferrals@duke.edu or 919-681-6468.
What is Involved?
We are doing this study to find out if an experimental drug (CDX-527) is a safe and effective treatment for your cancer.